244 related articles for article (PubMed ID: 28263849)
1. Chemical profiles and pharmacological activities of Chang-Kang-Fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome.
Mao Q; Shi L; Wang ZG; Luo YH; Wang YY; Li X; Lu M; Ju JM; Xu JD; Kong M; Zhou SS; Shen MQ; Li SL
J Ethnopharmacol; 2017 Apr; 201():123-135. PubMed ID: 28263849
[TBL] [Abstract][Full Text] [Related]
2. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway.
Zhang S; Tian D; Xia Z; Yang F; Chen Y; Yao Z; He Y; Miao X; Zhou G; Yao X; Tang J
J Ethnopharmacol; 2024 Aug; 330():118236. PubMed ID: 38670405
[TBL] [Abstract][Full Text] [Related]
3. Co-existing polysaccharides affect the systemic exposure of major bioactive ingredients in Chang-Kang-Fang, a multi-herb prescription for treatment of irritable bowel syndrome.
Zhong P; Zhou J; Fan YT; Guo MF; Zhu H; Zhou SS; Zhu JH; Zhang HH; Zhou GR; Miao XL; Li SL; Mao Q
J Ethnopharmacol; 2022 Nov; 298():115601. PubMed ID: 35963422
[TBL] [Abstract][Full Text] [Related]
4. Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome.
Ling X; Peng S; Zhong J; Guo L; Xu Y; Jin X; Chu F
Front Pharmacol; 2022; 13():778032. PubMed ID: 35614949
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome.
Sun J; Zhang M; Liu W; Liu Y; Zhang D; Fan X; Zhang J; Li T; Lu M
Front Microbiol; 2023; 14():1160783. PubMed ID: 37440881
[TBL] [Abstract][Full Text] [Related]
6. Deciphering chemical and metabolite profiling of Chang-Kang-Fang by UPLC-Q-TOF-MS/MS and its potential active components identification.
Yang F; Zhang S; Tian D; Zhou G; Tang X; Miao X; He Y; Yao X; Tang J
Chin J Nat Med; 2023 Jun; 21(6):459-480. PubMed ID: 37407177
[TBL] [Abstract][Full Text] [Related]
7. Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome.
Wang FY; Su M; Zheng YQ; Wang XG; Kang N; Chen T; Zhu EL; Bian ZX; Tang XD
Acta Pharmacol Sin; 2015 Jun; 36(6):708-15. PubMed ID: 25960135
[TBL] [Abstract][Full Text] [Related]
8. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P.
Yin Y; Zhong L; Wang JW; Zhao XY; Zhao WJ; Kuang HX
World J Gastroenterol; 2015 Apr; 21(15):4536-46. PubMed ID: 25914462
[TBL] [Abstract][Full Text] [Related]
9. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
Shi HL; Liu CH; Ding LL; Zheng Y; Fei XY; Lu L; Zhou XM; Yuan JY; Xie JQ
World J Gastroenterol; 2015 Apr; 21(16):4852-63. PubMed ID: 25944998
[TBL] [Abstract][Full Text] [Related]
10. Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways.
Xie Y; Zhan X; Tu J; Xu K; Sun X; Liu C; Ke C; Cao G; Zhou Z; Liu Y
J Ethnopharmacol; 2021 May; 272():113925. PubMed ID: 33592255
[TBL] [Abstract][Full Text] [Related]
11. Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats.
Zhao XY; Wang JW; Yin Y; Li K; Zhang M; Yan FP
World J Gastroenterol; 2019 Sep; 25(34):5134-5151. PubMed ID: 31558862
[TBL] [Abstract][Full Text] [Related]
12. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
[TBL] [Abstract][Full Text] [Related]
13. Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome.
Liang WJ; Zhang G; Luo HS; Liang LX; Huang D; Zhang FC
Gut Liver; 2016 May; 10(3):382-90. PubMed ID: 26446924
[TBL] [Abstract][Full Text] [Related]
14. Regulatory mechanism of electroacupuncture in irritable bowel syndrome: preventing MC activation and decreasing SP VIP secretion.
Wu HG; Jiang B; Zhou EH; Shi Z; Shi DR; Cui YH; Kou ST; Liu HR
Dig Dis Sci; 2008 Jun; 53(6):1644-51. PubMed ID: 17999187
[TBL] [Abstract][Full Text] [Related]
15. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive Effect of Ghrelin in a Rat Model of Irritable Bowel Syndrome Involves TRPV1/Opioid Systems.
Mao Y; Li Z; Chen K; Yu H; Zhang S; Jiang M; Ma Y; Liang C; Liu H; Li H; Hua Q; Zhou H; Sun Y; Fan X
Cell Physiol Biochem; 2017; 43(2):518-530. PubMed ID: 28930716
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Chang'an No. I Recipe on 5-hydroxytryptamine Signal System and mRNA Expression Levels of Hippocampal Brain Derived Neurotrophic Factor in Visceral Hypersensitivity Rats with Irritable Bowel Syndrome].
Zhao YP; Su M; Wang FY; Bian ZX; Yang JQ; Wang W; Tang XD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1228-35. PubMed ID: 26677676
[TBL] [Abstract][Full Text] [Related]
18. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.
Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Sim J; Jang KS
Scand J Gastroenterol; 2014 Jan; 49(1):43-51. PubMed ID: 24256141
[TBL] [Abstract][Full Text] [Related]
19. Quercetin Attenuates Visceral Hypersensitivity and 5-Hydroxytryptamine Availability in Postinflammatory Irritable Bowel Syndrome Rats: Role of Enterochromaffin Cells in the Colon.
Qin HY; Zang KH; Zuo X; Wu XA; Bian ZX
J Med Food; 2019 Jul; 22(7):663-671. PubMed ID: 30920336
[TBL] [Abstract][Full Text] [Related]
20. Integrating multiple-chromatographic approaches to evaluate chemical consistency of Chang-Kang-Fang preparations from mixed-herb decoction and combined single-herb decoction.
Fan YT; Zhong P; Xu JD; Zhou SS; Kong M; Zhou GR; Mao Q; Li SL
J Pharm Biomed Anal; 2021 Sep; 203():114186. PubMed ID: 34118572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
